Speaker 1: Takashi SHIMADA, Shimadzu Corporation, Japan Title: Streamlining a rapid and universal therapeutic antibody quantitation using Fab-selective proteolysis nSMOL-based multiplexed LC-MS/MS platform in clinical practice Topic: nSMOL technology...
shimadzu.eu
